Target intelligence / Profile preview

Volatile sulfur compound (produced by oral plaque bacteria) (VSC)

Target
VSC
Molecular classification
Small organic molecule (hydrogen sulfide, methyl mercaptan, dimethyl sulfide)
01

Overview

Volatile sulfur compounds are small, malodorous gases produced mainly by Gram-negative anaerobic oral plaque bacteria during the enzymatic breakdown of sulfur-containing amino acids (notably L-cysteine and L-methionine). The most clinically relevant VSCs are hydrogen sulfide, methyl mercaptan, and dimethyl sulfide, which together account for the vast majority of intra-oral halitosis. These compounds are markers for poor oral hygiene and periodontal disease, with their concentration strongly correlating with gingivitis and periodontitis severity. Their production is not attributed to a single molecular entity but is the result of metabolic activity by a diverse group of oral bacteria including *Porphyromonas gingivalis*, *Treponema denticola*, *Tannerella forsythia*, *Prevotella intermedia*, and others[1][2][3][4]. Detection and quantification of VSCs is used in diagnosing and monitoring halitosis and periodontal disease[2][4].

Other names
Volatile sulfur compoundsoral malodor gasesVSChalitosis-associated sulfur compoundshydrogen sulfidemethyl mercaptandimethyl sulfide
02

Mechanism of action

Antimicrobial inhibition of VSC-producing bacteria; Chemical neutralization or oxidation of VSCs

03

Biological functions

Decomposition of sulfur-containing amino acids (by oral bacteria)Contributor to oral malodor (halitosis)
04

Disease associations

Oral malodor (halitosis)Periodontal disease (periodontitis, gingivitis)
05

Safety considerations

Not applicable for VSCs as therapeutic targets; however, excessive antimicrobial use may disrupt oral microbiota or cause side effects.
06

Interacting drugs

Antibacterial oral hygiene agents (chlorhexidine, cetylpyridinium chloride, essential oils)

1 more in the full profile.

07

Biomarkers

VSC concentration in breath as diagnostic marker for halitosis and periodontal disease, notably hydrogen sulfide and methyl mercaptan

Beyond the preview

Go deeper on Volatile sulfur compound (produced by oral plaque bacteria) (VSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volatile sulfur compound (produced by oral plaque bacteria) (VSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call